Helicos Names CTO to Boost R&D

8/26/08

Helicos BioSciences (NASDAQ:HLCS), a Cambridge, MA, developer of DNA sequencing systems, announced today it promoted its senior vice president of product development, Bill Efcavitch, to chief technology officer. Helicos said the promotion of Efcavitch and two other appointments in senior research positions are intended to accelerate research and development at the company.

By posting a comment, you agree to our terms and conditions.